Abstract:BACKGROUND:Translocation of high-mobility group box 1 (HMGB1) from nucleus could trigger inflammation. Extracellular HMGB1 up-regulates inflammatory response in sepsis as a late mediator. However, little was known about its role in subarachnoid hemorrhage-inducible inflammation, especially in the early stage. This study aims to identify whether HMGB1 translocation occurred early after SAH and also to clarify the potential role of HMGB1 in brain injury following SAH.METHODS:Sprague-Dawley (SD) rats were randomly divided into sham group and SAH groups at 2 h, 12 h and on day 1, day 2. SAH groups suffered experimental subarachnoid hemorrhage by injection of 0.3 ml autoblood into the pre-chiasmatic cistern. Rats injected by recombinant HMGB1(rHMGB1) solution were divided into four groups according to different time points. Cultured neurons were assigned into control group and four hemoglobin (Hb) incubated groups. Mixed glial cells were cultured and stimulated in medium from neurons incubated by Hb. HMGB1 expression is measured by western blot analysis, real-time polymerase chain reaction (PCR), immunohistochemistry and immunofluorescence. Downstream nuclear factor kappa B (NF-κB) subunit P65 and inflammatory factor Interleukin 1β (IL-1β) were measured by western blot and real-time PCR, respectively. Brain injury was evaluated by cleaved caspase-3 staining.RESULTS:Our results demonstrated HMGB1 translocation occurred as early as 2 h after experimental SAH with mRNA and protein level increased. Immunohistochemistry and immunofluorescence results indicated cytosolic HMGB1 was mainly located in neurons while translocated HMGB1 could also be found in some microglia. After subarachnoid injection of rHMGB1, NF-κB, downstream inflammatory response and cleaved caspase-3 were up-regulated in the cortex compared to the saline control group. In-vitro, after Hb incubation, HMGB1 was also rapidly released from neurons to medium. Incubation with medium from neurons up-regulated IL-1β in mixed glial cells. This effect could be inhibited by HMGB1 specific inhibitor glycyrrhizic acid (GA) treatment.CONCLUSION:HMGB1 was released from neurons early after SAH onset and might trigger inflammation as an upstream inflammatory mediator. Extracellular HMGB1 contributed to the brain injury after SAH. These results might have important implications during the administration of specific HMGB1 antagonists early in order to prevent or reduce inflammatory response following SAH.

High-mobility Group Box1 Protein Promotes Neuroinflammation after Intracerebral Hemorrhage in Rats

Blockade of High Mobility Group Box-1 Signaling Via the Receptor for Advanced Glycation End-Products Ameliorates Inflammatory Damage after Acute Intracerebral Hemorrhage

Effects of high-mobility group box1 on cerebral angiogenesis and neurogenesis after intracerebral hemorrhage.

Elevation of High-Mobility Group Protein Box-1 in Serum Correlates with Severity of Acute Intracerebral Hemorrhage

Activation of the High-Mobility Group Box 1 Protein-Receptor for Advanced Glycation End-Products Signaling Pathway in Rats During Neurogenesis after Intracerebral Hemorrhage

HMGB1 May Act Via RAGE to Promote Angiogenesis in the Later Phase after Intracerebral Hemorrhage

Early Release of High-Mobility Group Box 1 (HMGB1) from Neurons in Experimental Subarachnoid Hemorrhage in Vivo and in Vitro.

HMGB1/TLR4 axis promotes pyroptosis after ICH by activating the NLRP3 inflammasome

HMGB1 promotes neurovascular remodeling via Rage in the late phase of subarachnoid hemorrhage

The Role of High Mobility Group Box 1 Protein in Acute Cerebrovascular Diseases

The Role of High Mobility Group Box 1 in Ischemic Stroke

Role of HMGB1 Translocation to Neuronal Nucleus in Rat Model with Septic Brain Injury.

Potential anti-inflammatory effect of anti-HMGB1 in animal models of ICH by downregulating the TLR4 signaling pathway and regulating the inflammatory cytokines along with increasing HO1 and NRF2

Early accumulation of high-mobility group box 1 protein in penumbra region of the brain following transient middle cerebral arterial occlusion in the rat

Early Antagonism of Cerebral High Mobility Group Box-1 Protein is Benefit for Sepsis Induced Brain Injury.

The Roles of High Mobility Group Box 1 in Cerebral Ischemic Injury

Inhibiting HMGB1 with Glycyrrhizic Acid Protects Brain Injury after DAI Via Its Anti-Inflammatory Effect

Microglial Polarization and Inflammatory Mediators After Intracerebral Hemorrhage

HMGB1: A New Target for Ischemic Stroke and Hemorrhagic Transformation

Role of PDGF-D and PDGFR-β in Neuroinflammation in Experimental ICH Mice Model

High mobility group box-1 protein promotes astrocytic CCL5 production through the MAPK/NF-κB pathway following spinal cord injury